Clinical Trial

A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer

Study acronym: TRANSPARENT
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study aims to investigate toripalimab with chemotherapy in participants with nasopharyngeal cancer.
Protocol Amendment History 18 amendments
This ClinicalTrials.gov record has been amended 18 times since 2024-06-10; most recent amendment 2026-07-14.
Status change: Not Yet Recruiting → Recruiting 2024-11-04
Trial Details
NCT Number NCT06457503
Lead Sponsor Coherus Oncology, Inc.
Conditions Nasopharyngeal Cancer Recurrent
Enrollment 100 participants
Start Date 2024-11-01
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-30